InTouch robots cleared for high-acuity patient monitoring
The FDA has expanded its clearance of InTouch Health’s remote-presence (RP) monitors to allow use of the telemedicine technology in a number of acute-care environments.
The manufacturer’s RP line can now roll into rooms for pre-operative, peri-operative and post-surgical assessments and examinations, along with cardiovascular, neurological, pre-natal, psychological and critical-care rounds and visits, according to a news release.
The approved models include RP-7i, RP-Lite, RP-Vantage and RP-Xpress, as well as the VisitOR1, which is made by InTouch but distributed by El Segundo, Calif.-based Karl Storz.
Dr. Yulun Wang, InTouch’s chairman and CEO, said the expanded clearance will facilitate clinical applications that are important to healthcare providers in the company’s core markets, those being telestroke and tele-ICU.
The company’s headquarters are in Santa Barbara, Calif.
The manufacturer’s RP line can now roll into rooms for pre-operative, peri-operative and post-surgical assessments and examinations, along with cardiovascular, neurological, pre-natal, psychological and critical-care rounds and visits, according to a news release.
The approved models include RP-7i, RP-Lite, RP-Vantage and RP-Xpress, as well as the VisitOR1, which is made by InTouch but distributed by El Segundo, Calif.-based Karl Storz.
Dr. Yulun Wang, InTouch’s chairman and CEO, said the expanded clearance will facilitate clinical applications that are important to healthcare providers in the company’s core markets, those being telestroke and tele-ICU.
The company’s headquarters are in Santa Barbara, Calif.
Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.